JP2010538093A5 - - Google Patents

Download PDF

Info

Publication number
JP2010538093A5
JP2010538093A5 JP2010524197A JP2010524197A JP2010538093A5 JP 2010538093 A5 JP2010538093 A5 JP 2010538093A5 JP 2010524197 A JP2010524197 A JP 2010524197A JP 2010524197 A JP2010524197 A JP 2010524197A JP 2010538093 A5 JP2010538093 A5 JP 2010538093A5
Authority
JP
Japan
Prior art keywords
ere
promoter
gene
sequence
tnf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010524197A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010538093A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/075468 external-priority patent/WO2009033075A1/en
Publication of JP2010538093A publication Critical patent/JP2010538093A/ja
Publication of JP2010538093A5 publication Critical patent/JP2010538093A5/ja
Pending legal-status Critical Current

Links

JP2010524197A 2007-09-07 2008-09-05 シソ科ファミリーのセイタカナミキソウのエストロゲン性抽出物およびその使用 Pending JP2010538093A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97079307P 2007-09-07 2007-09-07
PCT/US2008/075468 WO2009033075A1 (en) 2007-09-07 2008-09-05 ESTROGENIC EXTRACTS OF Scuttelaria barbata D. DON OF THE LABIATAE FAMILY AND USES THEREOF

Publications (2)

Publication Number Publication Date
JP2010538093A JP2010538093A (ja) 2010-12-09
JP2010538093A5 true JP2010538093A5 (https=) 2011-04-14

Family

ID=40429380

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010524197A Pending JP2010538093A (ja) 2007-09-07 2008-09-05 シソ科ファミリーのセイタカナミキソウのエストロゲン性抽出物およびその使用

Country Status (6)

Country Link
US (1) US9155770B2 (https=)
EP (1) EP2190292A4 (https=)
JP (1) JP2010538093A (https=)
AU (1) AU2008296136A1 (https=)
CA (1) CA2698747A1 (https=)
WO (1) WO2009033075A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100303936A1 (en) * 2009-04-28 2010-12-02 Bionovo, Inc. A Delaware Corporation Method of reducing fat accumulation and inducing weight loss

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2616328B1 (fr) 1987-06-12 1990-03-02 Moet Hennessy Rech Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de murier, ou au moins une flavone, en particulier une kuwanone et composition pharmaceutique, notamment dermatologique, a activite depigmentante, ou anti-inflammatoire, ou cosmetique, l'incorporant
JPH01175942A (ja) * 1987-12-28 1989-07-12 Sanyo Kokusaku Pulp Co Ltd 抗ウイルス性医薬用組成物
GB9103075D0 (en) 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
US5837257A (en) * 1996-07-09 1998-11-17 Sage R&D Use of plant extracts for treatment of HIV, HCV and HBV infections
US5874084A (en) * 1996-07-19 1999-02-23 Yng-Wong; Quing Non Using complex herbal formulations to treat hot flashes
KR100221762B1 (ko) 1996-10-29 1999-09-15 이승기 에모딘의 항암제로서의 용도
AU746946B2 (en) * 1997-03-21 2002-05-09 Shiseido Company Ltd. Immunopotentiators
MC2441A1 (fr) 1997-07-31 1998-03-11 Exsymol Sa Composition cosmétique utile notamment pour le blanchiment de la peau et agent inhibiteur de la mélanogénèse comprenant une telle composition cosmétique
CN1059117C (zh) 1997-11-25 2000-12-06 董有本 蝎毒肿瘤丸及其制备方法
FR2784294B1 (fr) 1998-10-12 2000-11-17 Oreal Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique
US6304825B1 (en) * 1999-01-19 2001-10-16 Xerox Corporation Rotary encoder error compensation system and method for photoreceptor surface motion sensing and control
FR2791573B1 (fr) * 1999-03-30 2003-04-11 Pf Medicament Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate
WO2000069452A1 (en) * 1999-05-17 2000-11-23 Yoshio Takeda Remedies for cancer and infection with helicobacter pylori and process for producing the same
JP2001122871A (ja) 1999-10-26 2001-05-08 Nippon Kayaku Co Ltd エストロゲン様作用薬剤
CN1294009A (zh) 1999-10-28 2001-05-09 马金发 抗癌中药制剂及其置备方法
DE10031650A1 (de) * 2000-06-29 2002-01-17 Schwabe Willmar Gmbh & Co Verwendung von Extrakten aus Sophora flavescens oder Sophora subprostrata zur Prophylaxe und Therapie von Krankheitszuständen, die durch einen Mangel an Östrogenen oder durch andere hormonelle Dysregulationen verursacht werden
JP4693963B2 (ja) 2000-07-12 2011-06-01 丸善製薬株式会社 エストロゲン様作用剤、コラーゲン産生促進剤、及び線維芽細胞増殖剤
US6238707B1 (en) * 2000-10-11 2001-05-29 Zhang Chun Herbal hormone balance composition
JP2005501816A (ja) * 2000-12-12 2005-01-20 ワックヴォム リミテッド Ｓｃｕｔｅｌｌａｒｉａｅｂａｒｂａｔａｅから単離された活性な画分を含む組成物および使用方法
JP2002284696A (ja) 2001-03-28 2002-10-03 Doi Keiko ウイルス、真菌その他の菌性疾患の治療方法
US6551627B1 (en) 2001-05-03 2003-04-22 Holomed Pharmaceuticals, Ltd. Medicinal herbal compounds for the prevention and treatment of diabetes
KR100456981B1 (ko) 2001-07-14 2004-11-10 (주) 메드빌 식물추출물을 포함하는 골다공증 예방 또는 치료용 조성물및 그 제조 방법
US6855344B2 (en) * 2001-07-17 2005-02-15 Integrated Chinese Medicine Holdings, Ltd. Compositions and methods for prostate and kidney health and disorders, an herbal preparation
KR20030027208A (ko) 2001-09-14 2003-04-07 주식회사 바이오딕스 생약을 함유하는 관절염 치료용 조성물 및 그 제조방법
US6750248B2 (en) * 2001-11-09 2004-06-15 National University Of Singapore Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
US20050032882A1 (en) * 2002-03-06 2005-02-10 Sophie Chen Botanical extract compositions and methods of use
JP2004155779A (ja) 2002-10-16 2004-06-03 Taisho Pharmaceut Co Ltd 更年期症の予防・治療用経口組成物
AU2002952453A0 (en) * 2002-11-01 2002-11-21 Novogen Research Pty Ltd Aminated isoflavonoid derivatives and uses thereof
JP4474518B2 (ja) * 2003-03-28 2010-06-09 学校法人日本大学 ２−ヒドロキシイソフラバノンデヒドラターゼをコードするポリヌクレオチドおよびその応用
WO2005044179A2 (en) * 2003-06-27 2005-05-19 Hong Kong University Of Science And Technology Formulations containing astragalus extracts and uses thereof
ES2373663T3 (es) 2003-09-08 2012-02-07 Genyous Biomed International Inc. Composiciones de extractos botánicos para terapia de cáncer.
US20050196409A1 (en) * 2003-09-24 2005-09-08 James Dao Compositions of botanical extracts for treating malignancy-associated changes
US20050118290A1 (en) * 2003-12-02 2005-06-02 University Of Singapore Compositions and method for treatment of steroid/nuclear receptor-mediated diseases
US20050208159A1 (en) * 2004-03-16 2005-09-22 Kang Kyung S Phytoestrogenic composition comprising an extract of chinese licorice root, liquiritin or isoliquiritin
BRPI0510717B8 (pt) * 2004-05-06 2021-05-25 Bioresponse Llc uso de 3,3' diindolilmetano (dim) ou 2-(indol-3-ilmetil)-3,3´-diindolilmetano (ltr)
US20050260285A1 (en) * 2004-05-21 2005-11-24 Dimateeo-Leggio Giovina Healthy prostate formula
US7887851B2 (en) * 2004-06-07 2011-02-15 Kao Corporation Aromatase activator
JP4939425B2 (ja) * 2004-11-05 2012-05-23 ジェノミック ヘルス， インコーポレイテッド 乳癌の治療反応の予後および予測の分子指標
JP2008520588A (ja) * 2004-11-18 2008-06-19 ビオファーマコペ デジン アンテルナショナル インク． 植物抽出物およびその皮膚科使用法
KR100589050B1 (ko) 2004-11-23 2006-06-14 인하대학교 산학협력단 황기 추출물 및 그로부터 분리한 이소플라보노이드계화합물을 유효성분으로 하는 관절염 예방 및 치료용 조성물
WO2006062876A2 (en) * 2004-12-09 2006-06-15 Merck & Co., Inc. Estrogen receptor modulators
US7815949B2 (en) * 2004-12-17 2010-10-19 Bionovo, Inc. Estrogenic extracts of Morus alba and uses thereof
JP2008524221A (ja) 2004-12-17 2008-07-10 バイオノボ・インコーポレーテッド Ｅｐｉｍｅｄｉｕｍ属植物の抽出液を用いた方法
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
AU2006259583A1 (en) * 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
CN100349577C (zh) * 2005-08-25 2007-11-21 深圳海王药业有限公司 黄芩总黄酮提取物及黄芩苷在抗骨质疏松药物制备中的用途
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
HRP20170103T1 (hr) * 2005-12-21 2017-03-24 Janssen Pharmaceutica N.V. Triazolopiridazini kao modulatori tirozin kinaze
CN101073600A (zh) 2006-05-17 2007-11-21 赵赐安 一种治疗各种毒蛇咬伤的洗用解毒药
BRPI0713198A2 (pt) 2006-07-19 2012-10-16 Osurf Ohio State University Res Foundation modulares seletivos de receptores de androgênio, seus análogos e derivados, e seus usos
US7381432B2 (en) * 2006-09-19 2008-06-03 Jose Angel Olalde Menopause disorder synergistic phyto-nutraceutical composition
US20080319051A1 (en) * 2007-06-22 2008-12-25 Bionovo, Inc. Liquiritigenin and derivatives as selective estrogen receptor beta agonists
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
WO2009021196A1 (en) * 2007-08-08 2009-02-12 Bionovo, Inc. Extracts of ligustrum lucidum and uses thereof
JP2010539086A (ja) * 2007-09-07 2010-12-16 バイオノボ・インコーポレーテッド マメ科ファミリーのクズのエストロゲン性抽出物およびその使用
WO2009033025A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of asparagus conchinchinensis (lour.) merr of the liliaceae family and uses thereof
JP2010539085A (ja) * 2007-09-07 2010-12-16 バイオノボ・インコーポレーテッド マメ科ファミリーのキバナオウギのエストロゲン性抽出物およびその使用
US20090258942A1 (en) * 2008-04-14 2009-10-15 Bionovo, Inc. Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
EP2310024A4 (en) * 2008-05-06 2012-07-25 Bionovo Inc ESTROGENIC EXTRACTS FOR THE TREATMENT OF VAGINA AND VULVAATROPHY
EP2294402A2 (en) * 2008-06-05 2011-03-16 Bionovo Inc. Method of quantification of multiple bioactives from botanical compositons
US20090312437A1 (en) * 2008-06-06 2009-12-17 Bionovo, Inc., A Delaware Corporation Anthraquinones and Analogs from Rhuem palmatum for Treatment of Estrogen Receptor Beta-Mediated Conditions
WO2010053600A2 (en) * 2008-06-13 2010-05-14 Bionovo, Inc. Nyasol and analogs thereof for the treatment of estrogen receptor beta-mediated diseases

Similar Documents

Publication Publication Date Title
Arnaud et al. A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor
Carrozza et al. Interaction of the viral activator protein ICP4 with TFIID through TAF250
Yang et al. Identification of overlapping DNA-binding and centromere-targeting domains in the human kinetochore protein CENP-C
Eberhard et al. Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family
Al-Younis et al. The Arabidopsis thaliana K+-uptake permease 5 (AtKUP5) contains a functional cytosolic adenylate cyclase essential for K+ transport
Giguère et al. Determinants of target gene specificity for RORα1: monomeric DNA binding by an orphan nuclear receptor
Zhou et al. Factors (TAFs) required for activated transcription interact with TATA box-binding protein conserved core domain.
Andresson et al. Vacuolar H+-ATPase Mutants Transform Cells and Define a Binding Site for the Papillomavirus E5 Oncoprotein (∗)
JP2008301828A5 (https=)
Register et al. Human-murine chimeras of ICAM-1 identify amino acid residues critical for rhinovirus and antibody binding
Steele et al. Identification of a surface on the β-propeller protein RACK1 that interacts with the cAMP-specific phosphodiesterase PDE4D5
US20080141388A1 (en) Cell-Cycle Stress-Related Proteins and Methods of Use in Plants
Menotti et al. The murine homolog of human Nectin1δ serves as a species nonspecific mediator for entry of human and animal αherpesviruses in a pathway independent of a detectable binding to gD
Hashimoto et al. Identification of three MAPKKKs forming a linear signaling pathway leading to programmed cell death in Nicotiana benthamiana
Hay et al. Recognition mechanisms in the synthesis of animal virus DNA
Bire et al. Transposase concentration controls transposition activity: myth or reality?
Strauss et al. Studies on the origin-specific DNA-binding domain of simian virus 40 large T antigen
CA2391971A1 (en) Methods and means for regulation of gene expression
JP2010538093A5 (https=)
Seo et al. Alternatively spliced exon 5 of the FERM domain of protein 4.1 R encodes a novel binding site for erythrocyte p55 and is critical for membrane targeting in epithelial cells
AU710551B2 (en) Nucleic acid encoding a nervous tissue sodium channel
Zhou et al. The yeast TATA-binding protein (TBP) core domain assembles with human TBP-associated factors into a functional TFIID complex
Zhang et al. Mapping of equine lentivirus receptor 1 residues critical for equine infectious anemia virus envelope binding
Sunstrom et al. Determination of the origin-specific DNA-binding domain of polyomavirus large T antigen
CN103524608A (zh) 水稻穗颈节调控基因sui1及其用途